Brickell Biotech Q1 EPS $(0.08) Misses $(0.06) Estimate, Sales $92.00K Miss $140.00K Estimate

Brickell Biotech (NASDAQ: BBI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $92.00 thousand which missed the analyst consensus estimate of $140.00 thousand by 34.29 percent. This is a 441.18 percent increase over sales of $17.00 thousand the same period last year.